Metagenomi

About

Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development.

Emeryville,California,United States
101 - 250
https://www.metagenomi.co

Highlights

Details

Last Funding Type: Series A
Last Funding Money Raised: $26.37M
Industries: Artificial Intelligence,Biotechnology,Machine Learning,Therapeutics
Founded date: Jan 1, 2018
Number Of Employee: 101 - 250
Operating Status: Active
Legal Name: Metagenomi, Inc.

Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development. The company's metagenomics-powered discovery platform and analytical expertise reveal novel cellular machinery sourced from otherwise unknown organisms. Metagenomi forges these naturally evolved systems into powerful gene editing systems that are ultra-small, extremely efficient, highly specific, and have a decreased risk of the immune response. Metagenomi's goal is to revolutionize gene editing for the benefit of patients around the world.

The company was founded in 2018 and is headquartered in Emeryville, California.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

6

$356.97M

Metagenomi has raised a total of $356.97M in funding over 2 rounds. Their latest funding was raised on Nov 14, 2022 from a Corporate Round round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Nov 14, 2022	Corporate Round	$80M	1	Ionis Pharmaceuticals	—	Detail
Jan 25, 2022	Series B	$175M	18	Farallon Capital Management PFM Health Sciences	—	Detail
May 27, 2021	Grant	$600K	1	Cystic Fibrosis Foundation	—	Detail
Nov 12, 2020	Series A	$75M	7	Humboldt Fund Leaps by Bayer RA Capital Management	—	Detail
Aug 16, 2019	Series A	$26.37M	7	Bayer Humboldt Fund	—	Detail

Investments

Number of Investments

Number of Lead Investments

3

0

Metagenomi has made 3 investments. Their most recent investment was on Apr 28, 2020, when Aesthetic raised $3.10M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Apr 28, 2020 Aesthetic	Seed	$3.10M	Blockchain	—
Nov 6, 2019 Digits	Series A	$10.50M	Artificial Intelligence	—
May 9, 2019 Printify	Seed	$3M	E-Commerce	—

Investors

Number of Lead Investors

Number of Investors

9

26

Metagenomi is funded by 26 investors. Ionis Pharmaceuticals and Farallon Capital Management are the most recent investors.

Investor Name	Lead Investor	Funding Round
Ionis Pharmaceuticals	Yes	Corporate Round
Farallon Capital Management	Yes	Series B
PFM Health Sciences	Yes	Series B
Cystic Fibrosis Foundation	Yes	Grant
Bayer	Yes	Series A
Bristol Myers Squibb	—	Series B
Deep Track Capital	—	Series B
Eventide	—	Series B
Frazier Healthcare Partners	—	Series B
HOF Capital	—	Series B